Global /Japan /Healthcare /Drug Manufacturers - Specialty & Generic /4524

Morishita Jintan Co., Ltd.

4524

• TSE: 4524 • Delayed

2,234JPY 0%

13.94 USD

As of 14 June 2026, Morishita Jintan Co., Ltd. has a market cap of $57.23M USD, ranking #29606 globally and #2731 in Japan. It ranks #2676 in the Healthcare sector, and #152 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

29606

Country Rank

2731

Sector Rank

2676

Industry Rank

152

Key Stats

Market Cap

$57.23MUSD

9.16B JPY

Enterprise Value

$59.97MUSD

9.61B JPY

Revenue (TTM)

$80.42MUSD

12.87B JPY

EBITDA (TTM)

$8.43MUSD

1.35B JPY

Net Income (TTM)

$3.5MUSD

560.0M JPY

EBITDA Margin

10%

Profit Margin

4.3%

PE Ratio

16.3

PS Ratio

0.7

PB Ratio

0.7

EV/EBITDA

7.1

Company Profile

Country (HQ)

Japan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yuji Morishita open_in_new

Employees

356

Founded

1893

Website

jintan.co.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0.1%	-4.1%	-0.7%	3.7%	2.2%	6.7%	8.8%	13%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	4524 森下仁丹株式会社 ISIN: JP3924400009 Shares Out.: Shares Outstanding: 4.099M¹ Shares Float: 1.76M² TV: TradingView: TSE: 4524 SA: Stock Analysis: TYO: 4524 YF: Yahoo Finance: 4524.T GF: Google Finance: TYO: 4524 BA: Barron's: 4524 MS: Morningstar: XTKS: 4524	2,234 JPY	TV: TradingView: TSE: 4524 SA: Stock Analysis: TYO: 4524 YF: Yahoo Finance: 4524.T GF: Google Finance: TYO: 4524 BA: Barron's: 4524 MS: Morningstar: XTKS: 4524

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Morishita Jintan Co., Ltd.

Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In addition, the company offers OEM contract services. Further, it develops Jintan capsule technology that allows encapsulating various contents, such as powder, liquid, microbe or others. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Chuo, Japan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Japan)

Name	Market Cap (USD) diff.	PE	Country
Hisamitsu Pharmaceutical Co., Inc. TSE: 4530	$2.66B 425.23B JPY 5K%	22.5	Japan
Torii Pharmaceutical Co., Ltd. TSE: 4551	$1.11B 178.26B JPY 2K%	33.0	Japan
Euglena Co., Ltd. TSE: 2931	$350.57M 56.12B JPY 513%	-	Japan
Yomeishu Seizo Co.,Ltd. TSE: 2540	$347.7M 55.66B JPY 508%	74.9	Japan
AnGes, Inc. TSE: 4563	$128.51M 20.57B JPY 125%	-	Japan
Astena Holdings Co., Ltd. TSE: 8095	$121.54M 19.46B JPY 112%	8.6	Japan

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.75B 108.92B ILS 64K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 52K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 28K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 19K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 19K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 16K%	80.6	China

chevron_leftBack